Why not submit a poster to the upcoming ‘Recovery and purification of biosynthetic products: Downstream processing for the 21st century‘ meeting
See the following link for more information:
http://www.regonline.co.uk/down2013
Abstracts for poster presentation only can be submitted up to two weeks before the event. Please note that there will be a best poster prize.
Abstracts can be submitted to: abstracts@euroscicon.com
Where: Cineworld: The O2
Peninsula Square
London
SE10 0DX
United Kingdom
What: The growing interest in biotechnology development and the high demand for biopharmaceuticals have contributed to the growth of the global biopharmaceutical market, which now comprises over 200 prodcuts. This market has reached $106 billion in 2009 and is forecasted to grow with a CAGR of 11.2% by 2016.
The main challenges of the biopharmaceutical industry now are to increase the efficiency and reduce the costs of the manufacturing process, with respect to the protein recovery, purity and efficacy. Therefore, new strategies are being implemented for the upstream and downstream processing. In the upstream, genetic engineering and glycoengineering approaches, as well as single-use bioreactors are being developed and applied. However, as culture yields are continuously increasing, the bottleneck in the manufacturing process has shifted to the dowstream processing, which accounts for ~ 80% of the total production cost. Many aspects are being considered for improving economics in downstream processing, such as simplification of the chromatographic purification processes, application of membrane technology, crystallization and precipitation. This meeting will focus on the advances, innovation and challenges in the area of downstream processing of biopharmaceuticals.
This event has CPD accreditation and is part of
The 2013 BioProcessing Summit – www.BioprocessingSummit2013.com
